查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1750664

全球液态生物检体市场：市场规模、份额、趋势分析（按生物标记、技术、样本类型、应用、临床用途、最终用途、产品和地区）、细分市场预测（2025-2030 年）

Liquid Biopsy Market Size, Share & Trends Analysis Report By Biomarker, By Technology, By Sample Type, By Application, By Clinical Application, By End-use, By Product, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

液态生物检体市场的成长和趋势

根据Grand View Research, Inc.的最新报告，预计到2030年全球液态生物检体市场规模将达到228.8亿美元，2025年至2030年的复合年增长率为11.54%。

癌症发生率的上升和老年人口的成长是推动市场成长的主要因素。此外，使用先进的技术设备进行疾病的早期检测也是推动市场成长的主要因素之一。此外，在预测期内，人们对非侵入性治疗方法的日益偏好可能会带来丰厚的机会。

近年来，癌症患者数量显着增加，预计这一趋势还将持续一段时间。生活方式的显着改变使世界人口面临癌症疾病和致癌因素的风险。例如，根据美国癌症协会的数据，预计到2022年，全球新增癌症病例将达到190万，导致609,360人死亡。各大公司正致力于拓展临床液态生物检体领域的业务。

例如，2021年12月，Helio Health和Fulgent Genetics宣布推出HelioLiver，这是一种用于早期检测肝癌的新型液态生物检体检测。此液态生物检体检测将血清蛋白标记物与游离DNA甲基化模式结合。此外，新的研发活动正在推动新型液态生物检体技术的开发。例如，2022年7月，中佛罗里达大学宣布开发一种新型液态生物检体技术，该技术利用肺癌和乳癌的生物标记来促进早期检测并方便病情监测。

企业对液态生物检体日益增长的兴趣以及新产品核准的上升，进一步推动了市场的成长。此外，过去几年的研究也显示液态生物检体平台取得了积极的结果。各国政府和各监管机构也对该领域表现出浓厚的兴趣，并推广了多种突破性设备，以促进该技术的快速发展。随着各公司对该技术的广泛采用，以及政府的资金和倡议的支持，预计未来几年市场将会成长。

液态生物检体市场：概述

  • 基于技术，次世代定序 (NGS) 领域预计将在 2024 年以 76.17% 的最大收益占有率引领市场，并预计在预测期内以最快的复合年增长率成长。
  • 根据生物标记，循环性肿瘤细胞(CTC) 生物标记部分在 2024 年占据市场最大收益占有率，为 35.67%。预计外泌体/微泡部分在预测期内将以 13.82% 的最快复合年增长率增长。
  • 根据应用，肿瘤学领域在 2024 年占据最大的收益占有率，为 86.31%，占据市场主导地位。预计在预测期内，生殖健康领域将以 12.75% 的最快复合年增长率成长。
  • 根据最终用途，医院和实验室部门在 2024 年占据最大的收益占有率，为 42.44%，占据市场主导地位。预计专科诊所部门在预测期内的复合年增长率最快，为 12.16%。
  • 根据临床应用，治疗方法选择部分在 2024 年占据市场最大收益占有率，为 33.69%。预计在预测期内，早期筛检部分将以 12.38% 的最快复合年增长率成长。
  • 仪器部分占据市场主导地位，2024 年的收益占有率最大，为 46.74%。预计套件和试剂产品部分在预测期内将以显着的复合年增长率成长。
  • 根据样本类型，血液样本将在 2024 年占据市场最大收益占有率71.44%，预计在预测期内将保持主导地位。
  • 液态生物检体市场以北美为主，2024 年的收益占有率最大，为 51.15%。预计在预测期内，亚太地区液态生物检体市场将以 13.02% 的最快复合年增长率成长。

目录

第一章 分析方法与范围

第二章执行摘要

第三章 市场驱动因素、趋势与范围

  • 市场区隔和范围
  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
  • 市场驱动因素分析
    • 癌症发生率上升
    • 人口老化加剧
    • 技术进步
    • 非侵入性治疗越来越受欢迎
  • 市场限制分析
    • 重磅处方药专利到期
  • 商业环境分析
    • SWOT分析；按因素（政治/法律、经济/技术）
    • PESTEL分析

第四章 业务类型分析

  • 液态生物检体市场：按类型进行的变化分析
  • 血液样本
    • 血液样本市场（2018-2030）
  • 其他的
    • 其他市场（2018-2030）

第五章 生物标记业务分析

  • 液态生物检体市场：生物标记变异分析
  • 循环性肿瘤细胞（CTC）
    • 循环性肿瘤细胞（CTC）市场（2018-2030）
  • 循环肿瘤DNA（ctDNA）
    • 循环肿瘤DNA（ctDNA）市场（2018-2030）
  • 细胞外囊泡（EVs）
    • 细胞外囊泡（EV）市场（2018-2030）
  • 其他的
    • 其他市场（2018-2030）

第六章 依技术进行的业务分析

  • 液态生物检体市场：按技术进行的变化分析
  • 多基因平行分析（NGS）
    • 下一代系统 (NGS) 市场（2018-2030）
  • 单基因分析（PCR微阵列）
    • 单基因分析（PCR微阵列）市场（2018-2030）

第七章 按应用程式进行业务分析

  • 液态生物检体市场：按应用进行的变化分析
  • 癌症
    • 癌症市场（2018-2030）
  • 生殖医学
    • 生殖医学市场（2018-2030）
  • 其他的
    • 其他市场（2018-2030）

第八章 按最终用途分類的业务分析

  • 液态生物检体市场：按最终用途进行的变化分析
  • 医院和研究机构
    • 医院和实验室市场（2018-2030）
  • 专科诊所
    • 专科诊所市场（2018-2030）
  • 学术研究中心
    • 学术研究中心市场（2018-2030）
  • 其他的
    • 其他液态生物检体市场（2018-2030）

9. 按临床用途分類的业务分析

  • 液态生物检体市场：按临床应用进行的变化分析
  • 治疗方法方案
    • 治疗方法方案市场（2018-2030）
  • 治疗监测
    • 治疗监测市场（2018-2030）
  • 早期癌症筛检
    • 早期癌症筛检市场（2018-2030）
  • 復发监测
    • 復发监测市场（2018-2030）
  • 其他的
    • 其他液态生物检体市场（2018-2030）

第十章 产品业务分析

  • 液态生物检体市场：产品差异分析
  • 装置
    • 设备市场（2018-2030年）
  • 耗材套件和试剂
    • 耗材试剂套件和试剂市场（2018-2030）
  • 软体与服务
    • 软体与服务市场（2018-2030）

第十一章 区域业务分析

  • 液态生物检体市场占有率（按地区划分）（2024 年和 2030 年）
  • 北美洲
    • 北美液态生物检体市场（2018-2030）
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲液态生物检体市场（2018-2030）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 亚太液态生物检体市场（2018-2030）
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 拉丁美洲液态生物检体市场（2018-2030）
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 中东和非洲液态生物检体市场（2018-2030）
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第十二章竞争格局

  • 参与企业概况
  • 财务表现
  • 参与企业
    • 盐之领袖
    • 液态生物检体市场占有率分析（2024年）
    • 公司简介
    • 战略地图
Product Code: GVR-1-68038-105-4

Liquid Biopsy Market Growth & Trends:

The global liquid biopsy market size is expected to reach USD 22.88 billion by 2030, registering a CAGR of 11.54% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increasing prevalence of cancer and the growing geriatric population are major drivers expected to fuel market growth. Furthermore, the use of technologically advanced devices for early detection of diseases is one of the key factors driving the market. In addition, the increasing preference for noninvasive treatment procedures will offer lucrative opportunities in the forecast period.

In recent years, cases of cancer have been rising tremendously and the trend is projected to remain the same in the foreseeable future. A significant shift in lifestyle has exposed the global population to this disorder and has resulted in oncogenic factors. For instance, as per the American Cancer Society, in 2022, the number of new cancer cases is expected to reach 1.9 million, leading to 609,360 deaths. Companies are focusing on expanding their business operations in the clinical liquid biopsy space.

For instance, in December 2021, Helio Health and Fulgent Genetics announced the launch of the former's HelioLiver, a new liquid biopsy test for early liver cancer detection. This liquid biopsy test combines serum protein markers and cell-free DNA methylation patterns. Additionally, new research studies are aiding the development of novel liquid biopsy techniques. For instance, in July 2022, the University of Central Florida announced the development of a novel liquid biopsy technique that facilitates early detection using biomarker identification for lung and breast cancer, making the monitoring of conditions easier.

The enhanced interest of players in liquid biopsy and the increasing rate of approval of new products are further accelerating market growth. Moreover, in the past several years, studies have shown a positive outcome of liquid biopsy platforms. Governments and various regulatory bodies have also shown interest in the area by promoting multiple breakthrough devices for the rapid development of this technology. With the high adoption of the technology by various companies, along with the support of government funding and initiatives, the market is expected to grow in the coming years.

Liquid Biopsy Market Report Highlights:

  • Based on technology, the multi-gene-parallel analysis (NGS) segment led the market with the largest revenue share of 76.17% in 2024 and is anticipated to grow at the fastest CAGR over the forecast period.
  • Based on biomarker, the circulating tumor cells (CTC) biomarker segment led the market with the largest revenue share of 35.67% in 2024. The exosomes/microvesicles segment is anticipated to grow at the fastest CAGR of 13.82% over the forecast period.
  • Based on application, the cancer segment led the market with the largest revenue share of 86.31% in 2024.The reproductive health segment is anticipated to grow at the fastest CAGR of 12.75% over the forecast period.
  • Based on end use, the hospitals and laboratories segment led the market with the largest revenue share of 42.44% in 2024. The specialty clinics segment is anticipated to grow at the fastest CAGR of 12.16% over the forecast period.
  • Based on clinical application, the therapy selection segment led the market with the largest revenue share of 33.69% in 2024.The early screening segment is expected to grow at the fastest CAGR of 12.38% over the forecast period.
  • The instruments product segment dominated the market with the largest revenue share of 46.74% in 2024.The kits and reagents product segment is expected to grow at a significant CAGR during the forecast period.
  • Based on sample type, the blood sample segment led the market with the largest revenue share of 71.44% in 2024 and is projected to maintain its dominance over the forecast period.
  • North America dominated the liquid biopsy market with the largest revenue share of 51.15% in 2024.The liquid biopsy market in Asia Pacific is expected to grow at the fastest CAGR of 13.02% over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation
    • 1.1.1. Market Definitions
  • 1.2. Objectives
    • 1.2.1. Objective - 1
    • 1.2.2. Objective - 2
    • 1.2.3. Objective - 3
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers
    • 3.4.1. Increasing prevalence of cancer
    • 3.4.2. Growing geriatric population
    • 3.4.3. Technological advancements
    • 3.4.4. Increasing preference for noninvasive treatment
  • 3.5. Market Restraint Analysis
    • 3.5.1. Patent expiry of blockbuster drugs prescribed
  • 3.6. Business Environment Analysis
    • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
    • 3.6.2. Porter's Five Forces Analysis

Chapter 4. Type Business Analysis

  • 4.1. Liquid Biopsy Market: Type Movement Analysis
  • 4.2. Blood Sample
    • 4.2.1. Blood Sample Market, 2018 - 2030 (USD Million)
  • 4.3. Others
    • 4.3.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Biomarker Business Analysis

  • 5.1. Liquid Biopsy Market: Biomarker Movement Analysis
  • 5.2. Circulating Tumor Cells (CTCs)
    • 5.2.1. Circulating Tumor Cells (CTCs) Market, 2018 - 2030 (USD Million)
  • 5.3. Circulating Tumor DNA (ctDNA)
    • 5.3.1. Circulating Tumor DNA (ctDNA) Market, 2018 - 2030 (USD Million)
  • 5.4. Extracellular Vehicles (EVs)
    • 5.4.1. Extracellular Vehicles (EVs) Market, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Technology Business Analysis

  • 6.1. Liquid Biopsy Market: Technology Movement Analysis
  • 6.2. Multi-gene-parallel Analysis (NGS)
    • 6.2.1. Multi-gene-parallel Analysis (NGS) Market, 2018 - 2030 (USD Million)
  • 6.3. Single Gene Analysis (PCR Microarrays)
    • 6.3.1. Single Gene Analysis (PCR Microarrays) Market, 2018 - 2030 (USD Million)

Chapter 7. Application Business Analysis

  • 7.1. Liquid Biopsy Market: Application Movement Analysis
  • 7.2. Cancer
    • 7.2.1. Cancer Market, 2018 - 2030 (USD Million)
      • 7.2.1.1. Lung Cancer
        • 7.2.1.1.1. Lung Cancer Market, 2018 - 2030 (USD Million)
      • 7.2.1.2. Prostate Cancer
        • 7.2.1.2.1. Prostate Cancer Market, 2018 - 2030 (USD Million)
      • 7.2.1.3. Breast Cancer
        • 7.2.1.3.1. Breast Cancer Market, 2018 - 2030 (USD Million)
      • 7.2.1.4. Colorectal Cancer
        • 7.2.1.4.1. Colorectal Cancer Market, 2018 - 2030 (USD Million)
      • 7.2.1.5. Leukemia
        • 7.2.1.5.1. Leukemia Market, 2018 - 2030 (USD Million)
      • 7.2.1.6. Gastrointestinal Cancer
        • 7.2.1.6.1. Gastrointestinal Cancer Market, 2018 - 2030 (USD Million)
      • 7.2.1.7. Others
        • 7.2.1.7.1. Others Market, 2018 - 2030 (USD Million)
  • 7.3. Reproductive Health
    • 7.3.1. Reproductive Health Market, 2018 - 2030 (USD Million)
  • 7.4. Others
    • 7.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. End-Use Business Analysis

  • 8.1. Liquid Biopsy Market: End-Use Movement Analysis
  • 8.2. Hospitals and Laboratories
    • 8.2.1. Hospitals and Laboratories Market, 2018 - 2030 (USD Million)
  • 8.3. Specialty Clinics
    • 8.3.1. Specialty Clinics Market, 2018 - 2030 (USD Million)
  • 8.4. Academic and Research Centers
    • 8.4.1. Academic and Research Centers Market, 2018 - 2030 (USD Million)
  • 8.5. Others
    • 8.5.1. Others Liquid Biopsy Market, 2018 - 2030 (USD Million)

Chapter 9. Clinical Application Business Analysis

  • 9.1. Liquid Biopsy Market: Clinical Application Movement Analysis
  • 9.2. Therapy Selection
    • 9.2.1. Therapy Selection Market, 2018 - 2030 (USD Million)
  • 9.3. Treatment Monitoring
    • 9.3.1. Treatment Monitoring Market, 2018 - 2030 (USD Million)
  • 9.4. Early Cancer Screening
    • 9.4.1. Early Cancer Screening Market, 2018 - 2030 (USD Million)
  • 9.5. Recurrence Monitoring
    • 9.5.1. Recurrence Monitoring Market, 2018 - 2030 (USD Million)
  • 9.6. Others
    • 9.6.1. Others Liquid Biopsy Market, 2018 - 2030 (USD Million)

Chapter 10. Product Business Analysis

  • 10.1. Liquid Biopsy Market: Product Movement Analysis
  • 10.2. Instruments
    • 10.2.1. Instruments Market, 2018 - 2030 (USD Million)
  • 10.3. Consumables Kits, and Reagents
    • 10.3.1. Consumables Kits and Reagents Market, 2018 - 2030 (USD Million)
  • 10.4. Software and Services
    • 10.4.1. Software and Services Market, 2018 - 2030 (USD Million)

Chapter 11. Regional Business Analysis

  • 11.1. Liquid Biopsy Market Share, By Region, 2024 & 2030
  • 11.2. North America
    • 11.2.1. North America Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.2.2. U.S.
      • 11.2.2.1. Key Country Dynamics
      • 11.2.2.2. Target Disease Prevalence
      • 11.2.2.3. Competitive Scenario
      • 11.2.2.4. Regulatory Framework
      • 11.2.2.5. Reimbursement Scenario
      • 11.2.2.6. U.S. Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.2.3. Canada
      • 11.2.3.1. Key Country Dynamics
      • 11.2.3.2. Target Disease Prevalence
      • 11.2.3.3. Competitive Scenario
      • 11.2.3.4. Regulatory Framework
      • 11.2.3.5. Reimbursement Scenario
      • 11.2.3.6. Canada Liquid biopsy market, 2018 - 2030 (USD Million)
  • 11.3. Europe
    • 11.3.1. Europe Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.3.2. Germany
      • 11.3.2.1. Key Country Dynamics
      • 11.3.2.2. Target Disease Prevalence
      • 11.3.2.3. Competitive Scenario
      • 11.3.2.4. Regulatory Framework
      • 11.3.2.5. Reimbursement Scenario
      • 11.3.2.6. Germany Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.3.3. UK
      • 11.3.3.1. Key Country Dynamics
      • 11.3.3.2. Target Disease Prevalence
      • 11.3.3.3. Competitive Scenario
      • 11.3.3.4. Regulatory Framework
      • 11.3.3.5. Reimbursement Scenario
      • 11.3.3.6. UK Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.3.4. France
      • 11.3.4.1. Key Country Dynamics
      • 11.3.4.2. Target Disease Prevalence
      • 11.3.4.3. Competitive Scenario
      • 11.3.4.4. Regulatory Framework
      • 11.3.4.5. Reimbursement Scenario
      • 11.3.4.6. France Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.3.5. Italy
      • 11.3.5.1. Key Country Dynamics
      • 11.3.5.2. Target Disease Prevalence
      • 11.3.5.3. Competitive Scenario
      • 11.3.5.4. Regulatory Framework
      • 11.3.5.5. Reimbursement Scenario
      • 11.3.5.6. Italy Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.3.6. Spain
      • 11.3.6.1. Key Country Dynamics
      • 11.3.6.2. Target Disease Prevalence
      • 11.3.6.3. Competitive Scenario
      • 11.3.6.4. Regulatory Framework
      • 11.3.6.5. Reimbursement Scenario
      • 11.3.6.6. Spain Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.3.7. Denmark
      • 11.3.7.1. Key Country Dynamics
      • 11.3.7.2. Target Disease Prevalence
      • 11.3.7.3. Competitive Scenario
      • 11.3.7.4. Regulatory Framework
      • 11.3.7.5. Reimbursement Scenario
      • 11.3.7.6. Denmark Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.3.8. Sweden
      • 11.3.8.1. Key Country Dynamics
      • 11.3.8.2. Target Disease Prevalence
      • 11.3.8.3. Competitive Scenario
      • 11.3.8.4. Regulatory Framework
      • 11.3.8.5. Reimbursement Scenario
      • 11.3.8.6. Sweden Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.3.9. Norway
      • 11.3.9.1. Key Country Dynamics
      • 11.3.9.2. Target Disease Prevalence
      • 11.3.9.3. Competitive Scenario
      • 11.3.9.4. Regulatory Framework
      • 11.3.9.5. Reimbursement Scenario
      • 11.3.9.6. Norway Liquid biopsy market, 2018 - 2030 (USD Million)
  • 11.4. Asia Pacific
    • 11.4.1. Asia Pacific Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.4.2. Japan
      • 11.4.2.1. Key Country Dynamics
      • 11.4.2.2. Target Disease Prevalence
      • 11.4.2.3. Competitive Scenario
      • 11.4.2.4. Regulatory Framework
      • 11.4.2.5. Reimbursement Scenario
      • 11.4.2.6. Japan Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.4.3. China
      • 11.4.3.1. Key Country Dynamics
      • 11.4.3.2. Target Disease Prevalence
      • 11.4.3.3. Competitive Scenario
      • 11.4.3.4. Regulatory Framework
      • 11.4.3.5. Reimbursement Scenario
      • 11.4.3.6. China Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.4.4. India
      • 11.4.4.1. Key Country Dynamics
      • 11.4.4.2. Target Disease Prevalence
      • 11.4.4.3. Competitive Scenario
      • 11.4.4.4. Regulatory Framework
      • 11.4.4.5. Reimbursement Scenario
      • 11.4.4.6. India Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.4.5. South Korea
      • 11.4.5.1. Key Country Dynamics
      • 11.4.5.2. Target Disease Prevalence
      • 11.4.5.3. Competitive Scenario
      • 11.4.5.4. Regulatory Framework
      • 11.4.5.5. Reimbursement Scenario
      • 11.4.5.6. South Korea Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.4.6. Australia
      • 11.4.6.1. Key Country Dynamics
      • 11.4.6.2. Target Disease Prevalence
      • 11.4.6.3. Competitive Scenario
      • 11.4.6.4. Regulatory Framework
      • 11.4.6.5. Reimbursement Scenario
      • 11.4.6.6. Australia Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.4.7. Thailand
      • 11.4.7.1. Key Country Dynamics
      • 11.4.7.2. Target Disease Prevalence
      • 11.4.7.3. Competitive Scenario
      • 11.4.7.4. Regulatory Framework
      • 11.4.7.5. Reimbursement Scenario
      • 11.4.7.6. Thailand Liquid biopsy market, 2018 - 2030 (USD Million)
  • 11.5. Latin America
    • 11.5.1. Latin America Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.5.2. Brazil
      • 11.5.2.1. Key Country Dynamics
      • 11.5.2.2. Target Disease Prevalence
      • 11.5.2.3. Competitive Scenario
      • 11.5.2.4. Regulatory Framework
      • 11.5.2.5. Reimbursement Scenario
      • 11.5.2.6. Brazil Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.5.3. Mexico
      • 11.5.3.1. Key Country Dynamics
      • 11.5.3.2. Target Disease Prevalence
      • 11.5.3.3. Competitive Scenario
      • 11.5.3.4. Regulatory Framework
      • 11.5.3.5. Reimbursement Scenario
      • 11.5.3.6. Mexico Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.5.4. Argentina
      • 11.5.4.1. Key Country Dynamics
      • 11.5.4.2. Target Disease Prevalence
      • 11.5.4.3. Competitive Scenario
      • 11.5.4.4. Regulatory Framework
      • 11.5.4.5. Reimbursement Scenario
      • 11.5.4.6. Argentina Liquid biopsy market, 2018 - 2030 (USD Million)
  • 11.6. MEA
    • 11.6.1. MEA Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.6.2. South Africa
      • 11.6.2.1. Key Country Dynamics
      • 11.6.2.2. Target Disease Prevalence
      • 11.6.2.3. Competitive Scenario
      • 11.6.2.4. Regulatory Framework
      • 11.6.2.5. Reimbursement Scenario
      • 11.6.2.6. South Africa Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.6.3. Saudi Arabia
      • 11.6.3.1. Key Country Dynamics
      • 11.6.3.2. Target Disease Prevalence
      • 11.6.3.3. Competitive Scenario
      • 11.6.3.4. Regulatory Framework
      • 11.6.3.5. Reimbursement Scenario
      • 11.6.3.6. Saudi Arabia Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.6.4. UAE
      • 11.6.4.1. Key Country Dynamics
      • 11.6.4.2. Target Disease Prevalence
      • 11.6.4.3. Competitive Scenario
      • 11.6.4.4. Regulatory Framework
      • 11.6.4.5. Reimbursement Scenario
      • 11.6.4.6. UAE Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.6.5. Kuwait
      • 11.6.5.1. Key Country Dynamics
      • 11.6.5.2. Target Disease Prevalence
      • 11.6.5.3. Competitive Scenario
      • 11.6.5.4. Regulatory Framework
      • 11.6.5.5. Reimbursement Scenario
      • 11.6.5.6. Kuwait Liquid biopsy market, 2018 - 2030 (USD Million)

Chapter 12. Competitive Landscape

  • 12.1. Participant's overview
  • 12.2. Financial performance
  • 12.3. Participant categorization
    • 12.3.1. Market Leaders
    • 12.3.2. Liquid Biopsy Market Share Analysis, 2024
    • 12.3.3. Company Profiles
      • 12.3.3.1. ANGLE plc
        • 12.3.3.1.1. Company Overview
        • 12.3.3.1.2. Financial Performance
        • 12.3.3.1.3. Product Benchmarking
        • 12.3.3.1.4. Strategic Initiatives
      • 12.3.3.2. Oncimmune Holdings PLC
        • 12.3.3.2.1. Company Overview
        • 12.3.3.2.2. Financial Performance
        • 12.3.3.2.3. Product Benchmarking
        • 12.3.3.2.4. Strategic Initiatives
      • 12.3.3.3. Guardant Health
        • 12.3.3.3.1. Company Overview
        • 12.3.3.3.2. Financial Performance
        • 12.3.3.3.3. Product Benchmarking
        • 12.3.3.3.4. Strategic Initiatives
      • 12.3.3.4. Myriad Genetics, Inc.
        • 12.3.3.4.1. Company Overview
        • 12.3.3.4.2. Financial Performance
        • 12.3.3.4.3. Product Benchmarking
        • 12.3.3.4.4. Strategic Initiatives
      • 12.3.3.5. Biocept, Inc.
        • 12.3.3.5.1. Company Overview
        • 12.3.3.5.2. Financial Performance
        • 12.3.3.5.3. Product Benchmarking
        • 12.3.3.5.4. Strategic Initiatives
      • 12.3.3.6. Lucence Health Inc.
        • 12.3.3.6.1. Company Overview
        • 12.3.3.6.2. Financial Performance
        • 12.3.3.6.3. Product Benchmarking
        • 12.3.3.6.4. Strategic Initiatives
      • 12.3.3.7. Freenome Holdings, Inc.
        • 12.3.3.7.1. Company Overview
        • 12.3.3.7.2. Financial Performance
        • 12.3.3.7.3. Product Benchmarking
        • 12.3.3.7.4. Strategic Initiatives
      • 12.3.3.8. F. Hoffmann-La Roche Ltd.
        • 12.3.3.8.1. Company Overview
        • 12.3.3.8.2. Financial Performance
        • 12.3.3.8.3. Product Benchmarking
        • 12.3.3.8.4. Strategic Initiatives
      • 12.3.3.9. QIAGEN
        • 12.3.3.9.1. Company Overview
        • 12.3.3.9.2. Financial Performance
        • 12.3.3.9.3. Product Benchmarking
        • 12.3.3.9.4. Strategic Initiatives
      • 12.3.3.10. Illumina, Inc.
        • 12.3.3.10.1. Company Overview
        • 12.3.3.10.2. Financial Performance
        • 12.3.3.10.3. Product Benchmarking
        • 12.3.3.10.4. Strategic Initiatives
      • 12.3.3.11. Thermo Fisher Scientific, Inc.
        • 12.3.3.11.1. Company Overview
        • 12.3.3.11.2. Financial Performance
        • 12.3.3.11.3. Product Benchmarking
        • 12.3.3.11.4. Strategic Initiatives
      • 12.3.3.12. Epigenomics AG
        • 12.3.3.12.1. Company Overview
        • 12.3.3.12.2. Financial Performance
        • 12.3.3.12.3. Product Benchmarking
        • 12.3.3.12.4. Strategic Initiatives
    • 12.3.4. Strategy Mapping
      • 12.3.4.1. Expansion
      • 12.3.4.2. Acquisition
      • 12.3.4.3. Collaborations
      • 12.3.4.4. Disease Type/Drug Class Launch
      • 12.3.4.5. Partnerships
      • 12.3.4.6. Others

List of Tables

  • Table 1 Global Liquid Biopsy Market, By Region, 2018 - 2030 (USD Million)
  • Table 2 Global Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 3 Global Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 4 Global Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 5 Global Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 6 Global Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 7 Global Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 8 Global Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 9 North America Liquid Biopsy Market, By Country, 2018 - 2030 (USD Million)
  • Table 10 North America Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 11 North America Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 12 North America Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 13 North America Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 14 North America Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 15 North America Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 16 North America Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 17 U.S. Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 18 U.S. Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 19 U.S. Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 20 U.S. Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 21 U.S. Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 22 U.S. Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 23 U.S. Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 24 Canada Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 25 Canada Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 26 Canada Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 27 Canada Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 28 Canada Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 29 Canada Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 30 Canada Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 31 Europe Liquid Biopsy Market, By Country, 2018 - 2030 (USD Million)
  • Table 32 Europe Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 33 Europe Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 34 Europe Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 35 Europe Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 36 Europe Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 37 Europe Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 38 Europe Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 39 UK Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 40 UK Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 41 UK Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 42 UK Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 43 UK Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 44 UK Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 45 UK Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 46 Germany Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 47 Germany Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 48 Germany Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 49 Germany Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 50 Germany Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 51 Germany Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 52 Germany Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 53 France Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 54 France Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 55 France Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 56 France Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 57 France Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 58 France Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 59 France Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 60 Italy Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 61 Italy Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 62 Italy Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 63 Italy Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 64 Italy Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 65 Italy Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 66 Italy Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 67 Spain Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 68 Spain Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 69 Spain Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 70 Spain Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 71 Spain Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 72 Spain Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 73 Spain Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 74 Denmark Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 75 Denmark Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 76 Denmark Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 77 Denmark Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 78 Denmark Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 79 Denmark Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 80 Denmark Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 81 Sweden Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 82 Sweden Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 83 Sweden Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 84 Sweden Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 85 Sweden Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 86 Sweden Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 87 Sweden Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 88 Norway Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 89 Norway Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 90 Norway Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 91 Norway Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 92 Norway Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 93 Norway Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 94 Norway Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 95 Asia Pacific Liquid Biopsy Market, By Country, 2018 - 2030 (USD Million)
  • Table 96 Asia Pacific Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 97 Asia Pacific Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 98 Asia Pacific Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 99 Asia Pacific Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 100 Asia Pacific Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 101 Asia Pacific Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 102 Asia Pacific Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 103 Japan Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 104 Japan Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 105 Japan Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 106 Japan Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 107 Japan Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 108 Japan Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 109 Japan Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 110 China Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 111 China Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 112 China Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 113 China Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 114 China Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 115 China Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 116 China Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 117 India Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 118 India Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 119 India Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 120 India Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 121 India Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 122 India Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 123 India Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 124 Australia Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 125 Australia Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 126 Australia Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 127 Australia Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 128 Australia Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 129 Australia Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 130 Australia Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 131 South Korea Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 132 South Korea Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 133 South Korea Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 134 South Korea Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 135 South Korea Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 136 South Korea Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 137 South Korea Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 138 Thailand Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 139 Thailand Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 140 Thailand Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 141 Thailand Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 142 Thailand Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 143 Thailand Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 144 Thailand Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 145 Latin America Liquid Biopsy Market, By Country, 2018 - 2030 (USD Million)
  • Table 146 Latin America Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 147 Latin America Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 148 Latin America Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 149 Latin America Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 150 Latin America Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 151 Latin America Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 152 Latin America Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 153 Brazil Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 154 Brazil Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 155 Brazil Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 156 Brazil Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 157 Brazil Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 158 Brazil Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 159 Brazil Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 160 Mexico Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 161 Mexico Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 162 Mexico Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 163 Mexico Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 164 Mexico Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 165 Mexico Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 166 Mexico Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 167 Argentina Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 168 Argentina Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 169 Argentina Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 170 Argentina Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 171 Argentina Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 172 Argentina Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 173 Argentina Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 174 Middle East & Africa Liquid Biopsy Market, By Country, 2018 - 2030 (USD Million)
  • Table 175 Middle East & Africa Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 176 Middle East & Africa Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 177 Middle East & Africa Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 178 Middle East & Africa Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 179 Middle East & Africa Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 180 Middle East & Africa Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 181 Middle East & Africa Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 182 South Africa Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 183 South Africa Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 184 South Africa Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 185 South Africa Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 186 South Africa Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 187 South Africa Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 188 South Africa Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 189 Saudi Arabia Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 190 Saudi Arabia Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 191 Saudi Arabia Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 192 Saudi Arabia Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 193 Saudi Arabia Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 194 Saudi Arabia Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 195 Saudi Arabia Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 196 UAE Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 197 UAE Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 198 UAE Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 199 UAE Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 200 UAE Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 201 UAE Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 202 UAE Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 203 Kuwait Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 204 Kuwait Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 205 Kuwait Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 206 Kuwait Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 207 Kuwait Liquid Biopsy Market, By End Use, 2018 - 2030 (USD Million)
  • Table 208 Kuwait Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 209 Kuwait Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Liquid biopsy market segmentation
  • Fig. 8 Market driver relevance analysis (Current & future impact)
  • Fig. 9 Market restraint relevance analysis (Current & future impact)
  • Fig. 10 Market challenge relevance analysis (Current & future impact)
  • Fig. 11 Penetration & growth prospect mapping
  • Fig. 12 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Market penetration vs growth prospect mapping
  • Fig. 15 Liquid biopsy market: Sample Type movement analysis
  • Fig. 16 Blood sample liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 17 Other liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 18 Liquid biopsy market: Biomarker movement analysis
  • Fig. 19 Circulating Tumor Cells (CTCs) liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 20 Circulating Tumor DNA (ctDNA) liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 21 Extracellular Vehicles (EVs) liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 22 Other liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 23 Liquid biopsy market: Technology movement analysis
  • Fig. 24 Multi-gene-parallel analysis (NGS) liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 25 Single gene analysis (PCR Microarrays) liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 26 Liquid biopsy market: Application movement analysis
  • Fig. 27 Cancer liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 28 Lung cancer liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 29 Prostate cancer liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 30 Breast cancer liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 31 Colorectal cancer liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 32 Leukemia liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 33 Gastrointestinal cancer liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 34 Other liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 35 Reproductive Health liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 36 Other liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 37 Liquid biopsy market: End Use movement analysis
  • Fig. 38 Hospitals and Laboratories liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 39 Specialty clinics liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 40 Academic and research centers liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 41 Other liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 42 Liquid biopsy market: Clinical application movement analysis
  • Fig. 43 Therapy selection liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 44 Treatment monitoring liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 45 Early cancer screening liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 46 Recurrence monitoring liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 47 Other liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 48 Liquid biopsy market: Product movement analysis
  • Fig. 49 Instruments liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 50 Consumables kits and reagents liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 51 Software and Services liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 52 Regional marketplace: Key takeaways
  • Fig. 53 Regional outlook, 2018 & 2030
  • Fig. 54 North America liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 55 U.S. liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 56 Canada liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 57 Europe liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 58 UK liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 59 Germany liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 60 Italy liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 61 Spain liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 62 France liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 63 Denmark liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 64 Sweden liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 65 Norway liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 66 Asia Pacific liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 67 Japan liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 68 China liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 69 India liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 70 Australia liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 71 South Korea liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 72 Thailand liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 73 Latin America liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 74 Brazil liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 75 Mexico liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 76 Argentina liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 77 MEA liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 78 South Africa liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 79 Saudi Arabia liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 80 UAE liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 81 Kuwait liquid biopsy market, 2018 - 2030 (USD Million)